Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About AHAF
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the link below.

Sign up for new RFP announcements and submission deadline notifications.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.
 
Researchers:
Have you heard a story, statistic, or discovery that might interest the public? Let us know about it!
 
AHAF Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

  

Macular Degeneration Research - Current Award

Dr. Erica Fletcher

Erica Fletcher, O.D., Ph.D.

The University of Melbourne
Melbourne, Australia

Title: Reducing photoreceptor death in dry AMD using anti-purinergic agents
Non-Technical Title: Ways of reducing vision loss in an animal model of Age-Related Macular Degeneration

Duration: April 1, 2010 - March 31, 2012
Award Type: Standard
Award Amount: $99,196


Summary:

We think that a molecule called ATP is released from dying photoreceptors early in the course of age-related macular degeneration that causes and accelerates the death of neighboring cells. In addition, we predict that drugs that block the actions of ATP will slow photoreceptor death and ultimately preserve vision. This project will examine this question in an animal model of age-related macular degeneration.

Details:

Vision loss in some forms of age related macular degeneration is associated with the death of cells called photoreceptors. This project will determine whether substances released from dying photoreceptors cause the death of neighboring photoreceptors causing acceleration of vision loss. In addition we will examine whether treatments that block the actions of these released substances (called ATP) slow the death of photoreceptors and preserve vision. This project addresses a novel mechanism of photorecepetor death, and considers whether a relatively unexplored class of drug can be used in the treatment of retina disease.

We will first examine how photoreceptors die in an animal model of age-related macular degeneration, and specifically look for evidence that a molecule called ATP is released from dying photoreceptors. Secondly, we will treat animals with novel compounds that block the actions of ATP and see whether this slows disease progression.

This is an important study because drugs that block the actions of ATP are already under intense investigation for possible use in treating pain. At the conclusion of this project, the mechanisms that are involved in photoreceptor death during age-related macular degeneration will be better understood. In addition, specific information about the value of using drugs that block the action of ATP will be known.